Hallucinogenic mushrooms may hold the key to treating anxiety, depression in cancer patients

Researchers might be closing in on a far-out approach to treating anxiety and depression in cancer patients. Two new studies released Thursday indicate that just one dose of psilocybin, a substance found only in hallucinogenic mushrooms, could immediately cut anxiety and depression in cancer patients for as long as eight months.
Two separate trials, the results of which were both published in the Journal of Psychopharmacology, found side effects of the drug to be "minimal," and results to be apparent in about "about 80 percent" of patients, The New York Times reported. "In spite of their unique vulnerability and the mood disruption that the illness and contemplation of their death has prompted, these participants have the same kind of experiences, that are deeply meaningful, spiritually significant, and producing enduring positive changes in life and mood and behavior," said Professor Roland Griffiths, who led the study at the Johns Hopkins University School of Medicine.
Psilocybin, along with other hallucinogens, has been classified as a Schedule 1 drug in the U.S. for more than 40 years. Though these studies' findings were hailed as "the most profound to date in the medical use of psilocybin," scientists say much more research must be done.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Trump U-turns on weapons to Ukraine
Speed Read Unhappy with Putin, Trump decides the US will go back to arming Ukraine against Russia's attacks
-
Ukraine scrambles as Trump cuts weapons deliveries
Speed Read The halting of weapons shipments was driven by Pentagon policy chief Elbridge Colby, a Ukraine funding skeptic
-
IAEA: Iran could enrich uranium 'within months'
Speed Read The chief United Nations nuclear inspector, Rafael Grossi, says Iran could be enriching uranium again soon
-
One year after mass protests, why are Kenyans taking to the streets again?
today's big question More than 60 protesters died during demonstrations in 2024
-
Iran nukes program set back months, early intel suggests
Speed Read A Pentagon assessment says US bombing of Iranian nuclear sites only set the program back by months, not years. This contradicts President Donald Trump's claim.
-
Trump says Iran and Israel agreed to ceasefire
Speed Read This followed a night of Israeli airstrikes on Tehran and multiple waves of missiles fired by Iran
-
Israel strikes Iran, killing military and nuclear chiefs
Speed Read Israeli officials said the attack was a 'preemptive' strike on Iran's nuclear program
-
Israel deports Thunberg after seizing Gaza aid boat
speed read The Swedish activist was delivering food and medical aid to Palestine, highlighting the growing humanitarian crisis there